Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cell carcinoma treated with interferon alfa-2b [2]

Journal of the National Cancer Institute

Volumn 89, Issue 17, 1997, Pages 1316-1317

  Vermeulen, P B ^a   Dirix, L Y ^a   Martin, M ^a   Lemmens, J ^a   Van Oosterom, A T ^a  

^a SINT AUGUSTINUS HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL RESPONSE MODIFIER; RECOMBINANT ALPHA2B INTERFERON; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LETTER; PROTEIN EXPRESSION;

EID: 0030800870     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.17.1316     Document Type: Letter

References (12)